The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). 詳細を表示
State Street Global Advisors (SSGA) announced today that the SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an authorized claimant from a class action settlement related to Human...
NEW YORK, March 2 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) announced today it listed five new exchange traded funds (ETFs) issued by three separate issuers in February, bringing...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.81 | 2.04058624577 | 88.7 | 90.75 | 87.33 | 8614755 | 88.75799094 | SP |
4 | -0.8 | -0.876136239185 | 91.31 | 94.4 | 86.4 | 8494012 | 90.01306894 | SP |
12 | -7.74 | -7.87786259542 | 98.25 | 105.47 | 86.4 | 9135753 | 94.65607505 | SP |
26 | -7.7 | -7.84034212402 | 98.21 | 105.47 | 86.4 | 7904907 | 96.58379184 | SP |
52 | 2.82 | 3.21587410195 | 87.69 | 105.47 | 81.14 | 8933668 | 94.03077183 | SP |
156 | 2.51 | 2.85227272727 | 88 | 105.47 | 61.78 | 9925842 | 84.91890465 | SP |
260 | -4.64 | -4.87651077246 | 95.15 | 174.79 | 61.78 | 8478266 | 94.50143576 | SP |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約